相关实验视频

Updated: Apr 17, 2026

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy
08:51

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on: April 3, 2018

9.0K

通过合成剂量致死性来确定PLK1-过度表达癌症的可向漏洞

Chelsea E Cunningham1, Frederick S Vizeacoumar2, Yue Zhang1

  • 1Department of Oncology, College of Medicine, University of Saskatchewan, Saskatoon, SK S7N 5E5, Canada.

Cell genomics
|May 10, 2025
PubMed
概括

向IGF2BP2提供了针对染色体不稳定性 (CIN) 癌症的新策略. 抑制IGF2BP2降低了Polo样酶1 (PLK1) 水平,限制了CIN驱动的恶性瘤的瘤生长.

关键词:
在IGF2BP2BP2的基础上.在 IMP2 中,MP2 包含了 IMP2.PLK1 PLK1 的意思是染色体的不稳定性在体内使用CRISPR屏.扰乱-seqq 的情况.一个单细胞CRISPR查.合成剂量致死性 合成剂量致死性瘤异质性的异质性

更多相关视频

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.1K
Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

208

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.2K